OUI Inc.is pleased to announce that a research paper on the functionality of Smart Eye Camera (SEC) has been published in the peer-reviewed English journal “Diagnostics”.
Clinical Observation of Allergic Conjunctival Diseases with Portable and Recordable Slit-Lamp…
Background: The incidence of allergic conjunctival diseases (ACDs) is gradually increasing worldwide. Both…
This clinical study has proven that the diagnostic results are as reliable as existing slit-lamp microscope in the evaluation of the allergic conjunctival diseases using 32 eyes from 17 cases.
This is the first paper in the world to evaluate the allergic conjunctival diseases using a smartphone, and the results of this study suggest that the SEC, a portable medical device, can contribute to ophthalmic care in areas where conventional fixed slit-lamp microscopes are not available (developing countries, remote areas such as isolated islands, and during disasters). In addition, the SEC is a smartphone attachment that enables remote medical treatment even in remote areas.
OUI Inc. will continue further research and aim to reduce blindness in the world by 50% by 2025 by spreading the SEC both domestically and internationally.